Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvest Mi (di) Regulatory News (HMI)

Share Price Information for Harvest Mi (di) (HMI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 2.00
Ask: 2.40
Change: 0.00 (0.00%)
Spread: 0.40 (20.00%)
Open: 2.20
High: 2.20
Low: 2.20
Prev. Close: 2.20
HMI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appendix 3B

4 Jan 2016 09:29

RNS Number : 6931K
Harvest Minerals Limited
04 January 2016
 



Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12

 

 

Name of entity

HARVEST MINERALS LIMITED

 

ABN

12 143 303 388

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

a) Fully Paid Ordinary Shares

b) Unlisted options exp 31/05/2017 @ 8.8 pence post-consolidation (0.88 pence pre-consolidation)

c) Unlisted options exp 18/12/2020 @ 7.5 pence post-consolidation (0.75 pence pre-consolidation)

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

a) 1 for 10 consolidation of 823,491,666 pre-consolidation shares to 82,249,193 post consolidated shares

b) 1 for 10 consolidation of 130,410,000 pre-consolidation unlisted options to 13,041,000 post-consolidated unlisted options

c) 1 for 10 consolidation of 9,517,200 pre-consolidation options to 951,720 post-consolidated unlisted options

 

 

3

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

a) Fully Paid Ordinary Shares

b) Unlisted options exp 31/05/2017 @ 8.8 pence (AUD $0.19) (post consolidated basis)

c) Unlisted options exp 18/12/2020 @ 7.5 pence (AUD $0.16) (post consolidated basis).

 

The share consolidation was achieved through the conversion of 10 ordinary fully paid shares into one ordinary share and 10 unlisted options into one unlisted option as approved by shareholders at the general meeting held on 17 December 2015.

 

 

 

4

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

a) Yes

b) No - Shares issued on conversion will rank equally with all ordinary shares on issue

c) No - Shares issued on conversion will rank equally with all ordinary shares on issue

 

 

 

5

Issue price or consideration

 

N/A

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

Consolidation of capital whereby 10 existing securities will become 1 security on a post consolidation basis.

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

N/A

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

N/A

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

N/A

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

N/A

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

N/A

 

 

 

6f

Number of securities issued under an exception in rule 7.2

N/A

 

 

 

 

6g

If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation.

N/A

 

 

 

6h

If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

 

N/A

 

 

7

Dates of entering +securities into uncertificated holdings or despatch of certificates

4 January 2016

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the securities in section 2 if applicable)

82,249,193

Fully Paid Ordinary Shares

 

 

 

 

 

 

 

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the securities in section 2 if applicable)

13,041,000

 

 

 

 951,720

 

Unlisted options exp 31/05/2017 @ 8.8 pence (AUD $0.19)

 

Unlisted options exp 18/12/2020 @ 7.5 pence (AUD $0.16)

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

N/A

 

 

 

Part 2 ‑ Bonus issue or pro rata issue

11

Is security holder approval required?

N/A

12

Is the issue renounceable or non-renounceable?

N/A

13

Ratio in which the +securities will be offered

N/A

14

+Class of +securities to which the offer relates

N/A

15

+Record date to determine entitlements

N/A

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

N/A

 

17

Policy for deciding entitlements in relation to fractions

N/A

18

Names of countries in which the entity has +security holders who will not be sent new issue documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

N/A

19

Closing date for receipt of acceptances or renunciations

N/A

20

Names of any underwriters

N/A

21

Amount of any underwriting fee or commission

N/A

22

Names of any brokers to the issue

N/A

23

Fee or commission payable to the broker to the issue

N/A

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of +security holders

N/A

25

If the issue is contingent on +security holders' approval, the date of the meeting

N/A

26

Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled

N/A

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

N/A

28

Date rights trading will begin (if applicable)

N/A

 

29

Date rights trading will end (if applicable)

N/A

30

How do +security holders sell their entitlements in full through a broker?

N/A

31

How do +security holders sell part of their entitlements through a broker and accept for the balance?

N/A

32

How do +security holders dispose of their entitlements (except by sale through a broker)?

N/A

33

+Despatch date

N/A

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

34

Type of securities

(tick one)

 

(a)

Securities described in Part 1

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

 

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

 

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

37

A copy of any trust deed for the additional +securities

 

 

Entities that have ticked box 34(b)

 

38

Number of securities for which +quotation is sought

N/A

 

 

39

Class of +securities for which quotation is sought

N/A

 

 

40

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

N/A

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another security, clearly identify that other security)

N/A

 

 

 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the securities in clause 38)

 

 

 

N/A

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

· There is no reason why those +securities should not be granted +quotation.

 

· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

Sign here: Jonathan Hart Date: 4 January 2016

(Company Secretary)

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSUKRNNAARRR
Date   Source Headline
22nd Jul 20197:00 amRNSUpdate on Mining License
10th Jul 20197:00 amRNSNew Corporate Presentation
24th Jun 20197:00 amRNSHolding(s) in Company
3rd Jun 20197:00 amRNSQuestion and Answer Document
29th May 20197:00 amRNSAppointment of Sole Broker
1st Apr 20197:00 amRNSUpdated Corporate Presentation
29th Mar 20192:05 pmRNSSecond Price Monitoring Extn
29th Mar 20192:00 pmRNSPrice Monitoring Extension
29th Mar 201912:00 pmRNSUnaudited Interim Results
20th Feb 20197:00 amRNSSwitch to Grid Power
30th Jan 20197:00 amRNSUpdated Corporate Video
28th Jan 20197:00 amRNSStatement on Brumadinho Tailings Dam Failure
23rd Jan 20197:00 amRNSNew Corporate Presentation
21st Jan 20197:00 amRNSNew Corporate Website
28th Nov 20188:44 amRNSResult of AGM
28th Nov 20187:00 amRNSCorporate and Operational Update
26th Oct 20187:00 amRNSNotice of AGM
28th Sep 20187:00 amRNSFinal Results
26th Sep 20187:00 amRNSQuestion and Answer Document
17th Sep 20187:00 amRNSOutstanding Results from Agronomic Tests on Grass
10th Sep 20187:00 amRNSAppointment of Chief Financial Officer
27th Jul 20189:48 amRNSHolding(s) in Company
26th Jul 20187:00 amRNSStrategic Alliance with Major Fertiliser Company
23rd Jul 20187:29 amRNSIssue of Performance Shares
18th Jul 20187:00 amRNSArapua Project Update including MAPA Approval
28th Jun 201810:22 amRNSHolding(s) in Company
22nd Jun 20189:15 amRNSHolding(s) in Company
19th Jun 201810:49 amRNSHolding(s) in Company
18th Jun 201810:15 amRNSHolding(s) in Company
18th Jun 201810:15 amRNSHolding(s) in Company
18th Jun 201810:10 amRNSHolding(s) in Company
14th Jun 201810:45 amRNSHolding in Company
11th Jun 20183:12 pmRNSCompletion of £9.712 Million Fundraise
11th Jun 20187:02 amRNSDirector Dealing
11th Jun 20187:01 amRNSProposed placing to raise approximately £9 million
11th Jun 20187:00 amRNSNew 50kt Sales Order
23rd May 20187:00 amRNSIssue of Performance Shares
14th May 20182:05 pmRNSSecond Price Monitoring Extn
14th May 20182:00 pmRNSPrice Monitoring Extension
14th May 20189:00 amRNSPrice Monitoring Extension
14th May 20187:00 amRNSMAPA Application Conditionally Approved
20th Apr 20187:00 amRNSCorporate and Operational Update
5th Apr 20187:00 amRNSUpdated Corporate Video
29th Mar 20187:00 amRNSApproval of Final Exploration Report
28th Mar 20187:00 amRNSMAPA Certification Update
23rd Mar 20189:00 amRNSInterim Results
19th Mar 20181:05 pmRNSShareholder Conference Call Recording
19th Mar 20187:00 amRNSBoard Changes
8th Mar 20181:00 pmRNSShareholder Conference Call
7th Mar 20187:00 amRNSMajor Sales Contract Signed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.